Clinical trials
Completed Observational Immunoblastic Lymphadenopathy trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 2 |
| 2008 | 2 |
| 2009 | 1 |
| 2017 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Case Comprehensive Cancer Center | 1 |
| Chonbuk National University Hospital | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Mayo Clinic | 1 |
| Northwestern University | 1 |
| University of Nebraska | 1 |
| Vanderbilt University | 1 |
| Wake Forest University Health Sciences | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Immunoblastic Lymphadenopathy | 8 |
| Lymphoma, Large-Cell, Anaplastic | 8 |
| Burkitt Lymphoma | 7 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 7 |
| Lymphoma, B-Cell, Marginal Zone | 7 |
| Lymphoma, Follicular | 7 |
| Lymphoma, Large B-Cell, Diffuse | 7 |
| Lymphoma, Mantle-Cell | 7 |
| Lymphoma, Extranodal NK-T-Cell | 6 |
| Lymphoma, Large-Cell, Immunoblastic | 6 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.